Celastrol, a novel HSP90 inhibitor, depletes Bcr-Abl and induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation (Q39788947)
Jump to navigation
Jump to search
scientific article published on 12 October 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Celastrol, a novel HSP90 inhibitor, depletes Bcr-Abl and induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation |
scientific article published on 12 October 2009 |
Statements
1 reference
Celastrol, a novel HSP90 inhibitor, depletes Bcr-Abl and induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation (English)
1 reference
Zhongzheng Lu
1 reference
Yanli Jin
1 reference
Lin Qiu
1 reference
Yingrong Lai
1 reference
Jingxuan Pan
1 reference
12 October 2009
1 reference
1 reference
290
1 reference
2
1 reference
182-191
1 reference
Identifiers
1 reference
1 reference